“Using Evidence-based medicine (EBM) to identify what factors contribute to decision making in prescribing for schizophrenia: a qualitative thematic analysis

dc.contributor.advisorPaul Mullins
dc.contributor.authorTAHANI IBRAHIM ALGHAMDI
dc.date2020
dc.date.accessioned2022-05-29T11:32:05Z
dc.date.available2022-05-29T11:32:05Z
dc.degree.departmentClinical and Health Psychology
dc.degree.grantorSchool Of Psychology
dc.description.abstractSchizophrenia is a chronic, serious, and persistent mental disorder has a negative effect on behaviors, thoughts, and feelings of patients. Schizophrenia is one of the leading causes of disability on a world scale. Also, it is considered one of the major causes of death in the USA. Although the NICE guidelines did not recommend atypical antipsychotics over typical antipsychotics, or vice versa, previous studies showed that atypical antipsychotics are more likely to be prescribed by therapists. Consequently, there is a need to examine the factors that affect clinical decision making.
dc.identifier.urihttps://drepo.sdl.edu.sa/handle/20.500.14154/46610
dc.language.isoen
dc.title“Using Evidence-based medicine (EBM) to identify what factors contribute to decision making in prescribing for schizophrenia: a qualitative thematic analysis
sdl.thesis.levelMaster
sdl.thesis.sourceSACM - United Kingdom

Files

Copyright owned by the Saudi Digital Library (SDL) © 2025